Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.

Despite the inaccessibility of an "accessible" bathroom stall, columnist Dagmar Munn finds the humor in the situation.

A new dashboard by the ALS Association offers free and open access to real-world data from more than 4,000 people affected by ...

Columnist Juliet Taylor remembers her late husband, Jeff, on their anniversary, and reflects on the wonderful grandpa he ...

Researchers have identified new blood and spinal fluid biomarkers that could help track ALS progression and monitor treatment ...

ALS is more common in some parts of the U.S. than others and it has a very strong geographic association with MS, a new study ...

Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...

Diabetes was tied to a 3.3 times greater risk of earlier loss of walking ability in a study of amyotrophic lateral sclerosis ...

EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...

The FDA has granted orphan drug status to the experimental T-cell, or Treg, therapy CK0803, being developed by Cellenkos to treat ALS.

Living with ALS has taken a toll, but columnist Kristin Neva feels like she is doing better now than she has in a long time.

As her husband, Todd, celebrates his 55th birthday, columnist Kristin Neva reflects on what's changed since his diagnosis 15 years ago.